A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Clinical trial NCT02781311 · COMPLETED
Trial details
- NCT number
- NCT02781311
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-14
- Primary completion
- 2018-03-15
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.